1,408 results on '"Dietel, Manfred"'
Search Results
2. Testing for deficient mismatch repair and microsatellite instability: A focused update
3. Testung auf Mismatch-Reparatur-Defizienz und Mikrosatelliteninstabilität: Eine fokussierte Aktualisierung
4. Proficiency testing of PIK3CA mutations in HR+/HER2-breast cancer on liquid biopsy and tissue
5. Wilko Weichert: 22.09.1970–10.07.2023
6. Erratum zu: Testung auf Mismatch-Reparatur-Defizienz und Mikrosatelliteninstabilität
7. 20 years of pathology: from conventional histology to next-generation pathology
8. Towards computational fluorescence microscopy: Machine learning-based integrated prediction of morphological and molecular tumor profiles
9. MSI testing: What’s new? What should be considered?
10. Status quo of ALK testing in lung cancer: results of an EQA scheme based on in-situ hybridization, immunohistochemistry, and RNA/DNA sequencing
11. MSI-Testung: Was ist neu? Was ist zu beachten?
12. Qualitätssicherung in der dMMR- und MSI-Diagnostik
13. Obduktionen
14. Praktische Durchführung der ärztlichen Leichenschau – Aufgabenkomplexe
15. Harmonization and Standardization of Panel-Based Tumor Mutational Burden Measurement: Real-World Results and Recommendations of the Quality in Pathology Study
16. Qualitätssicherung in der diagnostischen In-situ-Hybridisierung – Erfahrungen der QuIP
17. A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal
18. Testing deficient mismatch repair and microsatellite instability
19. ALK IHC and FISH discordant results in patients with NSCLC and treatment response: for discussion of the question—to treat or not to treat?
20. Bone Marrow Work-up: Report of a Pilot Study
21. Clinical and analytical validation of Ki-67 in 9069 patients from IBCSG VIII + IX, BIG1-98 and GeparTrio trial: systematic modulation of interobserver variance in a comprehensive in silico ring trial
22. Remodeling of central metabolism in invasive breast cancer compared to normal breast tissue - a GC-TOFMS based metabolomics study
23. Erratum zu Mitteilungen der Deutschen Gesellschaft für Pathologie
24. Data from Atypical Protein Kinase C ζ Exhibits a Proapoptotic Function in Ovarian Cancer
25. Supplementary Data from Atypical Protein Kinase C ζ Exhibits a Proapoptotic Function in Ovarian Cancer
26. Personalized Medicine Challenges the Health Care System
27. Harmonized PD-L1 immunohistochemistry for pulmonary squamous-cell and adenocarcinomas
28. Ovar
29. Tube
30. Data from Novel Jet-Injection Technology for Nonviral Intratumoral Gene Transfer in Patients with Melanoma and Breast Cancer
31. Supplemental Table S2 from EGFR Mutation Status and First-Line Treatment in Patients with Stage III/IV Non–Small Cell Lung Cancer in Germany: An Observational Study
32. Supplementary Figures S1-S2 from ABCC2 (MRP2, cMOAT) Can Be Localized in the Nuclear Membrane of Ovarian Carcinomas and Correlates with Resistance to Cisplatin and Clinical Outcome
33. Supplementary Data from Class I Histone Deacetylase Expression Has Independent Prognostic Impact in Human Colorectal Cancer: Specific Role of Class I Histone Deacetylases In vitro and In vivo
34. EPI-14-1149 from EGFR Mutation Status and First-Line Treatment in Patients with Stage III/IV Non–Small Cell Lung Cancer in Germany: An Observational Study
35. Supplementary Table S1-S2 from ABCC2 (MRP2, cMOAT) Can Be Localized in the Nuclear Membrane of Ovarian Carcinomas and Correlates with Resistance to Cisplatin and Clinical Outcome
36. Supplementary Figure S1 from Novel Jet-Injection Technology for Nonviral Intratumoral Gene Transfer in Patients with Melanoma and Breast Cancer
37. Supplemental Methods, Figures 1-2, Table S1 from Standardized Ki67 Diagnostics Using Automated Scoring—Clinical Validation in the GeparTrio Breast Cancer Study
38. Supplementary Figures and Tables from Accumulated Metabolites of Hydroxybutyric Acid Serve as Diagnostic and Prognostic Biomarkers of Ovarian High-Grade Serous Carcinomas
39. Supplementary Materials and Methods, Tables 1-4, Figures 1-5 from Hyperactivation of the Insulin-like Growth Factor Receptor I Signaling Pathway Is an Essential Event for Cisplatin Resistance of Ovarian Cancer Cells
40. Supplementary Figure 1 from Mass Spectrometry–Based Metabolic Profiling Reveals Different Metabolite Patterns in Invasive Ovarian Carcinomas and Ovarian Borderline Tumors
41. Supplementary Table S2 from Accumulated Metabolites of Hydroxybutyric Acid Serve as Diagnostic and Prognostic Biomarkers of Ovarian High-Grade Serous Carcinomas
42. Supplementary Figure Legends from Accumulated Metabolites of Hydroxybutyric Acid Serve as Diagnostic and Prognostic Biomarkers of Ovarian High-Grade Serous Carcinomas
43. Supplementary Tables 1-3 from Mass Spectrometry–Based Metabolic Profiling Reveals Different Metabolite Patterns in Invasive Ovarian Carcinomas and Ovarian Borderline Tumors
44. Supplementary Methods from Accumulated Metabolites of Hydroxybutyric Acid Serve as Diagnostic and Prognostic Biomarkers of Ovarian High-Grade Serous Carcinomas
45. Supplementary Figure 2 from Mass Spectrometry–Based Metabolic Profiling Reveals Different Metabolite Patterns in Invasive Ovarian Carcinomas and Ovarian Borderline Tumors
46. Supplementary Figure Legends 1-3 from Mass Spectrometry–Based Metabolic Profiling Reveals Different Metabolite Patterns in Invasive Ovarian Carcinomas and Ovarian Borderline Tumors
47. Data from Mass Spectrometry–Based Metabolic Profiling Reveals Different Metabolite Patterns in Invasive Ovarian Carcinomas and Ovarian Borderline Tumors
48. Supplementary Figure 3 from Mass Spectrometry–Based Metabolic Profiling Reveals Different Metabolite Patterns in Invasive Ovarian Carcinomas and Ovarian Borderline Tumors
49. Wilms tumor protein 1 (WT1) — Not only a diagnostic but also a prognostic marker in high-grade serous ovarian carcinoma
50. Predictive Pathology of Cytostatic Drug Resistance and New Anti-cancer Targets
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.